4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004770
President sold 30,000 shares at an average $68.66 ($2,059,796)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
RUBINSTEIN JULIE · President
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-19 | Exercise or conversion : show line 1 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2021-01-19 | Sale : show line 2 in the form | −2,563 | $68.72 | $176,129 | 12,437 | D |
| 2021-01-19 | Sale : show line 3 in the form | −7,415 | $69.54 | $515,639 | 5,022 | D |
| 2021-01-19 | Sale : show line 4 in the form | −4,822 | $70.51 | $339,999 | 200 | D |
| 2021-01-19 | Sale : show line 5 in the form | −200 | $71.23 | $14,246 | 0 | D |
| 2021-01-20 | Exercise or conversion : show line 6 in the form | +15,000 | $6.32 | $94,800 | 15,000 | D |
| 2021-01-20 | Sale : show line 7 in the form | −4,366 | $66.49 | $290,295 | 10,634 | D |
| 2021-01-20 | Sale : show line 8 in the form | −4,264 | $67.58 | $288,161 | 6,370 | D |
| 2021-01-20 | Sale : show line 9 in the form | −6,370 | $68.34 | $435,326 | 0 | D |
| Open-market sales · 30,000 sh · avg $68.66 · $2,059,796 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-19 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −15,000 | 215,000 | D |
| 2021-01-20 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −15,000 | 200,000 | D |
Loading xslF345X03/doc4.xml…